144 related articles for article (PubMed ID: 2904909)
1. Serum methotrexate and human chorionic gonadotropin concentrations during five-day chemotherapy for low-risk metastatic gestational trophoblastic neoplasia.
Hilgers RD; Standefer JC; Bowling MC; Greeley P
Int J Gynaecol Obstet; 1988 Dec; 27(3):421-5. PubMed ID: 2904909
[TBL] [Abstract][Full Text] [Related]
2. High-dose methotrexate for gestational trophoblastic disease.
Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
[TBL] [Abstract][Full Text] [Related]
3. Correlation of plasma methotrexate concentration with human chorionic gonadotropin and therapeutic response to low-dose methotrexate-citrovorum factor in low-medium-risk gestational trophoblastic tumors.
Hilgers RD; Newlands ES; Hoffman R; Mitchell H; Bagshawe KD
Gynecol Oncol; 1991 May; 41(2):117-22. PubMed ID: 1646754
[TBL] [Abstract][Full Text] [Related]
4. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
Homesley HD; Blessing JA; Rettenmaier M; Capizzi RL; Major FJ; Twiggs LB
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):413-8. PubMed ID: 2457192
[TBL] [Abstract][Full Text] [Related]
5. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
Rotmensch J; Rosenshein NB; Block BS
Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia.
Kizaki S; Hashimoto K; Matsui H; Usui H; Shozu M
Gynecol Oncol; 2015 Dec; 139(3):429-32. PubMed ID: 26456138
[TBL] [Abstract][Full Text] [Related]
8. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
9. [The kinetics of chorionic gonadotropin and its subunits in normal pregnancy and gestational trophoblastic neoplasms].
Kunhardt J; Calderón J; RodrÃguez S; Fletcher P; Ayala A; Reyes V
Ginecol Obstet Mex; 1987 Jul; 55():188-91. PubMed ID: 2484840
[No Abstract] [Full Text] [Related]
10. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of metastatic trophoblastic disease after negative, plasma human chorionic gonadotropin beta-subunit assay.
McComb P; Ho Yuen B; Boyes D; White G
Gynecol Oncol; 1980 Feb; 9(1):114-6. PubMed ID: 6243596
[No Abstract] [Full Text] [Related]
12. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
[TBL] [Abstract][Full Text] [Related]
13. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
Berkowitz RS; Goldstein DP
Obstet Gynecol; 1979 Dec; 54(6):725-8. PubMed ID: 229448
[TBL] [Abstract][Full Text] [Related]
15. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
[TBL] [Abstract][Full Text] [Related]
16. Nonmetastatic gestational trophoblastic neoplasms.
Schlaerth JB
Gynecol Oncol; 1993 Feb; 48(2):137. PubMed ID: 8381373
[No Abstract] [Full Text] [Related]
17. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
[TBL] [Abstract][Full Text] [Related]
18. Identification of chemotherapeutic refractory cases based on human chorionic gonadotropin values among patients with low-risk persistent trophoblastic disease treated with 8-day methotrexate-folinic acid.
Shigematsu T; Hirakawa T; Yahata H; Sonoda T; Kinukawa N; Nakano H
Eur J Gynaecol Oncol; 2003; 24(2):113-6. PubMed ID: 12701958
[TBL] [Abstract][Full Text] [Related]
19. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
[TBL] [Abstract][Full Text] [Related]
20. Plasma methotrexate levels in patients with gestational trophoblastic neoplasia treated by two methotrexate regimens.
Rotmensch J; Rosenshein N; Donehower R; Dillon M; Villar J
Am J Obstet Gynecol; 1984 Mar; 148(6):730-4. PubMed ID: 6199978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]